Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
July 31, 2024
|
| In: |
The lancet
Year: 2024, Volume: 404, Issue: 10452, Pages: 527-539 |
| ISSN: | 1474-547X |
| DOI: | 10.1016/S0140-6736(24)00814-6 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S0140-6736(24)00814-6 Verlag, lizenzpflichtig, Volltext: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00814-6/fulltext |
| Author Notes: | Alwin Krämer, Tilmann Bochtler, Chantal Pauli, Kai-Keen Shiu, Natalie Cook, Juliana Janoski de Menezes, Roberto A. Pazo-Cid, Ferran Losa, Debbie GJ Robbrecht, Jiří Tomášek, Cagatay Arslan, Mustafa Özgüroğlu, Michael Stahl, Frédéric Bigot, Sun Young Kim, Yoichi Naito, Antoine Italiano, Nasséra Chalabi, Gonzalo Durán-Pacheco, Chantal Michaud, Jeremy Scarato, Marlene Thomas, Jeffrey S. Ross, Holger Moch, Linda Mileshkin |
| Item Description: | Gesehen am 28.01.2025 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1474-547X |
| DOI: | 10.1016/S0140-6736(24)00814-6 |